SurfingNASH.com

Surfing the MASH Tsunami

Health EN ↓ 1073 episodes

Driving the Discussion in Fatty Liver Disease. Join hepatology researcher and Key Opinion Leader Jörn Schattenberg, Liver Wellness Advocate Louise Campbell, and Forecasting and Pricing Guru Roger Green and a global group of Key Opinion Leaders and patient advocates as they discuss key issues in Fatty Liver disease, including epidemiology, drug development, clinical pathways, non-invasive testing, health economics and regulatory issues, from their own unique perspectives on the Surfing the MASH Tsunami podcast. #MASH #MAFLD #FattyLiver #livertwitter #AASLD #GlobalLiver #NoNASH #EASL

Author

SurfingNASH.com

Category

Health

Podcast website

surfingMASH.com

Latest episode

Oct 7, 2025

Where to listen?

Podcasts in the app Replaio Radio Coming soon

Podcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts

Get it on Google Play Install for free Android 5M+ downloads · 4.8 rating iOS soon

Episodes

S4-E34.1 - The Excitement of FASN Inhibitors: Positive 2B Interim Data for Denifanstat 29.07.2023

Send us Fan Mail This month, Surfing NASH embarks on a series of episodes dedicated to takeaways emerging from June's two major conferences: the 2023 EASL Congress in Vienna and the American Diabetes Association's 83rd Scientific Sessions meeting in San Diego. This is the second session focusing on drug development, and specifically, on several presentations for exciting drugs in develop...

S4-E34 - Drug Development Stories from EASL and ADA: Part 2 27.07.2023

Send us Fan Mail This month, Surfing NASH embarks on a series of episodes dedicated to takeaways emerging from June's two major conferences: the 2023 EASL Congress in Vienna and the American Diabetes Association's 83rd Scientific Sessions meeting in San Diego. This is the second session focusing on drug development, and specifically, on several presentations for exciting drugs in develop...

S4-E33.5 - From the Vault: ILC 2022 Looking Back: NASH Is a Complex Disease 23.07.2023

Send us Fan Mail The first three days of the 2022 program focused on a range of issues, with specific emphasis on non-invasive tests (NITs) and their role at different stages in diagnosis and treatment. This conversation From the Vault touches on two issues: use of AI to better understand the meaning of liver volume and elements of morphology and, relatedly, how much more sophisticated a view we t...

S4-E33.4 - More Presentation Insights on Frequency of Testing, NITs and Biopsy 23.07.2023

Send us Fan Mail Throughout the month of July, Surfing NASH embarks on a series of episodes dedicated to takeaways emerging from a busy past month at both the 2023 EASL Congress and the American Diabetes Association's 83rd Scientific Sessions . For this feature, Sven Francque (University of Antwerp) and Ian Rowe (University of Leeds) join Jörn Schattenberg and Roger Green to discuss a range o...

S4-E33.3 - Steatotic Liver Disease, HCC and Mechanisms of Fibrosis Resolution 22.07.2023

Send us Fan Mail Throughout the month of July, Surfing NASH embarks on a series of episodes dedicated to takeaways emerging from a busy past month at both the 2023 EASL Congress and the American Diabetes Association's 83rd Scientific Sessions . For this feature, Sven Francque (University of Antwerp) and Ian Rowe (University of Leeds) join Jörn Schattenberg and Roger Green to discuss a range o...

S4-E33.2 - Unmet Needs in the Primary Care Setting for Disease Identification 22.07.2023

Send us Fan Mail Throughout the month of July, Surfing NASH embarks on a series of episodes dedicated to takeaways emerging from a busy past month at both the 2023 EASL Congress and the American Diabetes Association's 83rd Scientific Sessions . For this feature, Sven Francque (University of Antwerp) and Ian Rowe (University of Leeds) join Jörn Schattenberg and Roger Green to discuss posters a...

S4-E33.1 - EASL Congress 2023: Focus on New Nomenclature 22.07.2023

Send us Fan Mail Throughout the month of July, Surfing NASH embarks on a series of episodes dedicated to takeaways emerging from a busy past month at both the 2023 EASL Congress and the American Diabetes Association's 83rd Scientific Sessions . For this feature, Sven Francque (University of Antwerp) and Ian Rowe (University of Leeds) join Jörn Schattenberg and Roger Green to discuss a range o...

S4-E33 - EASL Congress: Nomenclature and More Compelling Presentations 20.07.2023

Send us Fan Mail Throughout the month of July, Surfing NASH embarks on a series of episodes dedicated to takeaways emerging from a busy past month at both the 2023 EASL Congress and the American Diabetes Association's 83rd Scientific Sessions . For this feature, Sven Francque (University of Antwerp) and Ian Rowe (University of Leeds) join Jörn Schattenberg and Roger Green to discuss a range o...

S4-E32.5 - From the Vault: ILC 2022 Looking Back: Crystal Balling & The Semaglutide Trial 17.07.2023

Send us Fan Mail In 2022, roughly 5,000 liver community stakeholders gathered in London for the 2022 International Liver Congress (#ILC2022,) the first major hepatology Congress to be held in person since the start of the pandemic (smaller, but very valuable, meetings like NASH-TAG, LiverCONNECT and Paris NASH have taken place with an in-person component, but the International Liver Congress and T...

S4-E32.4 - The Potential of NASH Drugs as Adjuvant Therapy 16.07.2023

Send us Fan Mail Throughout the month of July, Surfing NASH embarks on a series of episodes dedicated to takeaways emerging from a busy past month at both the 2023 EASL Congress in Vienna and the American Diabetes Association's 83rd Scientific Sessions meeting in San Diego. To reflect on the insight-laden occasion, Stephen Harrison and Jörn Schattenberg join Roger Green to explore emerging dr...

S4-E32.3 - Discussing Other Drugs in the Therapeutic Landscape 15.07.2023

Send us Fan Mail Throughout the month of July, Surfing NASH embarks on a series of episodes dedicated to takeaways emerging from a busy past month at both the 2023 EASL Congress in Vienna and the American Diabetes Association's 83rd Scientific Sessions meeting in San Diego. To reflect on the insight-laden occasion, Stephen Harrison and Jörn Schattenberg join Roger Green to explore emerging dr...

S4-E32.2 - Why We Should Develop Deeper Understanding of Liver Volume 15.07.2023

Send us Fan Mail Throughout the month of July, Surfing NASH embarks on a series of episodes dedicated to takeaways emerging from a busy past month at both the 2023 EASL Congress in Vienna and the American Diabetes Association's 83rd Scientific Sessions meeting in San Diego. To reflect on the insight-laden occasion, Stephen Harrison and Jörn Schattenberg join Roger Green to explore emerging dr...

S4-E32.1 - Lead Principle Investigator Stephen Harrison Recaps the MAESTRO-NASH Program for Resmetirom 15.07.2023

Send us Fan Mail Throughout the month of July, Surfing NASH embarks on a series of episodes dedicated to takeaways emerging from a busy past month at both the 2023 EASL Congress in Vienna and the American Diabetes Association's 83rd Scientific Sessions meeting in San Diego. To reflect on the insight-laden occasion, Stephen Harrison and Jörn Schattenberg join Roger Green to explore emerging dr...

S4-E32 - Drug Development Stories from EASL and ADA: Part 1 13.07.2023

Send us Fan Mail Throughout the month of July, Surfing NASH embarks on a series of episodes dedicated to takeaways emerging from a busy past month at both the 2023 EASL Congress in Vienna and the American Diabetes Association's 83rd Scientific Sessions meeting in San Diego. For this feature, Stephen Harrison and Jörn Schattenberg discuss at depth drug development insights emerging from the me...

S4-E31.4 - EASL Congress and ADA Scientific Sessions: Reshaping the way we think about Fatty Liver Disease 09.07.2023

Send us Fan Mail Throughout the month of July, Surfing NASH embarks on a series of episodes dedicated to takeaways emerging from a busy last few weeks at both the 2023 EASL Congress in Vienna and the American Diabetes Association's 83rd Scientific Sessions meeting in San Diego. This first installment comprises two distinct 1:1 interviews with Tsunami co-host Roger Green, one with key opinion...

S4-E31.3 - Jörn Schattenberg on the Therapeutic Landscape and Fibrosis Resolution 09.07.2023

Send us Fan Mail Throughout the month of July, Surfing NASH embarks on a series of episodes dedicated to takeaways emerging from a busy last few weeks at both the 2023 EASL Congress in Vienna and the American Diabetes Association's 83rd Scientific Sessions meeting in San Diego. This first installment comprises two distinct 1:1 interviews with Tsunami co-host Roger Green, one with key opinion...

S4-E31.2 - What do we know about mechanisms of action in NASH drugs and the commercial implications? 09.07.2023

Send us Fan Mail Throughout the month of July, Surfing NASH embarks on a series of episodes dedicated to takeaways emerging from a busy last few weeks at both the 2023 EASL Congress in Vienna and the American Diabetes Association's 83rd Scientific Sessions meeting in San Diego. This first installment comprises two distinct 1:1 interviews with Tsunami co-host Roger Green, one with key opinion...

S4-E31.1 - Mazen Noureddin on "NASH Monopoly" 09.07.2023

Send us Fan Mail Throughout the month of July, Surfing NASH embarks on a series of episodes dedicated to takeaways emerging from a busy last few weeks at both the 2023 EASL Congress in Vienna and the American Diabetes Association's 83rd Scientific Sessions meeting in San Diego. This first installment comprises two distinct 1:1 interviews with Tsunami co-host Roger Green, one with key opinion...

S4-E31 - Mazen Noureddin and Jörn Schattenberg on the Developing Therapeutic Landscape 07.07.2023

Send us Fan Mail Throughout the month of July,  Surfing NASH embarks on a series of episodes dedicated to takeaways emerging from a busy last few weeks at both the 2023 EASL Congress in Vienna and the American Diabetes Association's 83rd Scientific Sessions meeting in San Diego.    This first installment comprises two distinct 1:1 interviews with Tsunami co-host Roger Green, one with key opin...

S4-E30.4 - EASL Congress 2023: Final Takeaways 02.07.2023

Send us Fan Mail Surfing NASH delivered a second wrap-up session on-site in Vienna as a part of its real-time coverage of a truly thought-provoking EASL Congress 2023 . This conversation held after the Saturday late breakers features key opinion leaders Hannes Hagström and Michelle Long, entrepreneur and epigenetics advocate Rachel Zayas and patient advocates Jeff McIntyre and Michael Betel alongs...

S4-E30.3 - EASL Congress 2023: More Posters and Presentations 02.07.2023

Send us Fan Mail Surfing NASH delivered a second wrap-up session on-site in Vienna as a part of its real-time coverage of a truly thought-provoking EASL Congress 2023 . This conversation held after the Saturday late breakers features key opinion leaders Hannes Hagström and Michelle Long, entrepreneur and epigenetics advocate Rachel Zayas and patient advocates Jeff McIntyre and Michael Betel alongs...

S4-E30.2 - EASL Congress 2023: Scoring Systems to Evaluate NASH 02.07.2023

Send us Fan Mail Surfing NASH delivered a second wrap-up session on-site in Vienna as a part of its real-time coverage of a truly thought-provoking EASL Congress 2023 . This conversation held after the Saturday late breakers features key opinion leaders Hannes Hagström and Michelle Long, entrepreneur and epigenetics advocate Rachel Zayas and patient advocates Jeff McIntyre and Michael Betel alongs...

S4-E30.1 - EASL Congress 2023: Nomenclature Rollout 02.07.2023

Send us Fan Mail Surfing NASH delivered an additional wrap-up session on-site in Vienna as a part of its real-time coverage of a truly thought-provoking EASL Congress 2023 . This is the first of four conversations held after the Saturday late breakers with key opinion leaders Hannes Hagström and Michelle Long, entrepreneur and epigenetics advocate Rachel Zayas and patient advocates Jeff McIntyre a...

S4-E29.3 - EASL Congress 2023: Final Thoughts on Days 1-3 01.07.2023

Send us Fan Mail Surfing NASH offered on-site coverage of EASL Congress 2023 in two separate real-time reviews. This conversation features the final session exploring the first three days of the meeting with Ian Rowe, Michael Betel, Jörn Schattenberg and Roger Green. The focus of the group ranges from discussion around the FGF-21 agents efruxifermin and pegozafermin to the results of two major scr...

S4-E29.2 - EASL Congress 2023: Challenges in Patient Screening and the “2nd Wave” of NASH Therapeutics 01.07.2023

Send us Fan Mail Surfing NASH offered on-site coverage of EASL Congress 2023 in two separate real-time reviews. This conversation continues from the first session featuring Ian Rowe, Michael Betel, Jörn Schattenberg and Roger Green and their focus on the first three days of the meeting. The group begins by discussing the Friday afternoon session that Jörn co-chaired which investigates the challeng...

Listen to the Surfing the MASH Tsunami podcast in Replaio

Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch

Get it on Google Play

Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.